We’re delighted to announce that the Milner Therapeutics Institute will play an active role at BioTrinity 2026 next month, with both a dedicated showcase session and participation in a key panel discussion focused on collaboration in life sciences. BioTrinity 2026 is the 20th edition of OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth.
As part of the conference programme on 14 April, the Institute will host the Milner Incubator Showcase (15:05–15:50), bringing together a selection of its incubator companies to highlight cutting-edge science and emerging partnerships. The session will feature a series of short presentations designed to demonstrate how collaboration between academia, industry and entrepreneurs is driving innovation and accelerating the translation of research into real-world impact.
On the same day, Milner Executive Director Cathy Tralau-Stewart will join the panel discussion Unlocking the Power of Collaboration (15:30–15:50). This session will explore how partnerships can be effectively leveraged as a core component of growth strategies for R&D-focused SMEs. Panellists will discuss how collaboration across academia, industry, investors and the NHS can help organisations accelerate development, share risk and extend capabilities. The discussion will also address practical considerations, including how to structure partnerships for long-term success and what distinguishes the most effective collaborative models in today’s life sciences ecosystem.
We look forward to taking part in BioTrinity and hope to see you there!
Find out more and register: obn.glueup.com/event/biotrinity-2026-140616/home.html
